RBC Europe’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-400	Closed	-$3.02K	–	1138
2018 Q2	$3.02K	Hold	400	–	–	﹤0.01%	1028
2018 Q1	$14K	Hold	400	–	–	﹤0.01%	751
2017 Q4	$17K	Buy	+400	New	+$17K	﹤0.01%	723